52875-47-5 Usage
Description
7,10-Dioxadispiro[2.2.4.2]dodecane is a cyclic ether chemical compound that belongs to the group of dioxanes. It features a unique spirocyclic structure with two oxygen atoms within a 12-membered ring, making it an intriguing molecule for various applications.
Uses
Used in Organic Synthesis:
7,10-Dioxadispiro[2.2.4.2]dodecane is used as a building block in organic synthesis for its interesting and complex molecular structure, which allows for the creation of novel materials and compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 7,10-Dioxadispiro[2.2.4.2]dodecane is utilized as a building block for the development of new pharmaceuticals, thanks to its unique structure that can contribute to the design of innovative drugs.
Used in Agrochemical Development:
7,10-Dioxadispiro[2.2.4.2]dodecane is employed as a component in the development of agrochemicals, where its complex structure can be leveraged to create new products for agricultural applications.
Used in Drug Delivery Systems:
7,10-Dioxadispiro[2.2.4.2]dodecane has been studied for its potential use in drug delivery systems, where its unique structure could enhance the delivery and effectiveness of pharmaceutical agents.
Used as a Chiral Building Block:
7,10-Dioxadispiro[2.2.4.2]dodecane is used as a chiral building block in the synthesis of complex molecules, which is valuable in creating enantiomerically pure compounds for various applications, including pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 52875-47-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,8,7 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 52875-47:
(7*5)+(6*2)+(5*8)+(4*7)+(3*5)+(2*4)+(1*7)=145
145 % 10 = 5
So 52875-47-5 is a valid CAS Registry Number.
52875-47-5Relevant articles and documents
KINASE INHIBITORS
-
Page/Page column 119; 120, (2021/10/15)
Disclosed herein are protein kinase inhibitors, in particular Bruton's tyrosine kinase (BTK) inhibitors, pharmaceutical compositions comprising them, processes for preparing them and uses of such protein kinase inhibitors to treat or prevent diseases, disorders and conditions associated with kinase function. In particular, the present invention relates to selective BTK inhibitors.
PYRROLO[2,3-C]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE
-
Page/Page column 74, (2018/08/03)
Disclosed are a pyrrolo[2,3-c]pyridine derivative, a preparation method therefor, and use thereof in medicine. Specifically, disclosed are a pyrrolo[2,3-c]pyridine derivative as represented by general formula (1), a preparation method therefor, a pharmaceutical composition comprising the derivative, as well as use thereof as a BRD4 inhibitor in the treatment of related diseases such as cancers, inflammations, chronic liver diseases, diabetes, cardiovascular diseases and AIDS, each substituent in general formula (I) being same as defined in the description.
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS
-
Page/Page column 117, (2014/10/03)
Compounds of formula I are provided, which are JAK inhibitors and are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
